Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?

• DOI: 10.1080/14656566.2024.2353627
• Publication Date: 2024-05-08T16:59:11Z
• Authors: Lea M Monday; Vishakh Keri; Pranatharthi H Ch...
• Keywords: Cytomegalovirus

Introduction Cytomegalovirus (CMV) remains a serious opportunistic infection in hematopoietic cell transplant (HCT) and solid-organ (SOT) recipients. Traditional anti-CMV drugs are limited by toxicities the development of resistance. Letermovir maribavir newly approved antivirals for prevention treatment CMV.